Related Experiment Video
Updated: Mar 15, 2026

11:57
Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury
Published on: February 23, 2015
9.8K
BMP7-Based Functionalized Self-Assembling Peptides Protect Nucleus Pulposus-Derived Stem Cells From Apoptosis In
Xiao-Chuan Li1,2,3, Yao-Hong Wu2, Xue-Dong Bai2
11 The Third Affiliated Hospital of Southern Medical University , Guangzhou, China .
Tissue Engineering. Part A
|September 2, 2016
Summary
Bone morphogenic protein 7 (BMP7)-functionalized peptides protect nucleus pulposus-derived stem cells (NPDCs) from apoptosis. This novel RADA-RKPS peptide enhances NPDC survival and proliferation, offering a promising strategy for intervertebral disc degeneration treatment.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Stem Cell Biology
Background:
- Intervertebral disc degeneration (IVDD) presents a significant challenge in tissue engineering due to the harsh cellular microenvironment.
- Existing biomaterials often fall short in protecting transplanted cells within the intervertebral disc.
- Novel biological therapies are crucial for overcoming these limitations and improving IVDD treatment outcomes.
Purpose of the Study:
- To develop and evaluate a novel bone morphogenic protein 7 (BMP7)-based functionalized self-assembling peptide for protecting nucleus pulposus-derived stem cells (NPDCs).
- To assess the efficacy of the RADA-RKPS peptide in enhancing NPDC survival, proliferation, and differentiation in an apoptosis-inducing environment.
Main Methods:
- Conjugation of a BMP-7 bioactive motif (RKPS) to the RADA16-I peptide to create RADA-RKPS.
- Culture of NPDCs with RADA-RKPS in an apoptosis-promoting environment induced by tumor necrosis factor-alpha.
- Evaluation of NPDC viability, proliferation, apoptosis rates (TUNEL staining), and apoptosis-related gene expression (BAX/BCL-2 ratio).
- Assessment of NPDC differentiation into nucleus pulposus-like cells by analyzing collagen II a1, aggrecan, and Sox-9 gene expression.
Main Results:
- RADA-RKPS significantly improved NPDC survival and proliferation compared to controls.
- The peptide markedly reduced NPDC apoptosis rates, as evidenced by TUNEL staining.
- RADA-RKPS effectively downregulated the BAX/BCL-2 ratio and upregulated key chondrogenic markers (collagen II a1, aggrecan, Sox-9) in NPDCs.
Conclusions:
- RADA-RKPS peptides demonstrate significant protective effects on NPDCs in a pro-apoptotic environment.
- These findings highlight the potential of RADA-RKPS as a novel therapeutic agent for intervertebral disc degeneration.
- The developed peptide offers a promising biological treatment strategy for IVDD by enhancing cell survival and promoting regenerative processes.

